Cargando…
Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome
The vast majority of the human proteome is yet to be functionally characterized thus hindering ongoing investigations on potential drug resistance mechanisms and advanced treatment options. Chemical proteomics is a powerful solution for enzyme profiling and the development of next generation cancer...
Autores principales: | Lee, Kristi Y., Chau, Cindy H., Price, Douglas K., Figg, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820805/ https://www.ncbi.nlm.nih.gov/pubmed/35129066 http://dx.doi.org/10.1080/15384047.2022.2033059 |
Ejemplares similares
-
A Suite
of Activity-Based Probes To Dissect the KLK
Activome in Drug-Resistant Prostate Cancer
por: Lovell, Scott, et al.
Publicado: (2021) -
Commentary: PROTACs make undruggable targets druggable: Challenge and opportunity
por: Lu, Bin, et al.
Publicado: (2021) -
Drugging the Undruggable: Advances on RAS Targeting in Cancer
por: Molina-Arcas, Miriam, et al.
Publicado: (2021) -
Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019) -
Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021)